DMK PHARMACEUTICALS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0372 USD | +23.42% |
|
+17.72% | -94.69% |
| 05-30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
| 05-08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 304K | - | - | - | - | - | |
| 780B | ||||||
| 627B | ||||||
| 334B | ||||||
| 296B | ||||||
| 244B |
